Mira G P Zuidgeest
Overview
Explore the profile of Mira G P Zuidgeest including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
212
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Jong A, Zuidgeest M, Santa-Ana-Tellez Y, Hallgreen C, van Sloten T, de Boer A, et al.
Drug Discov Today
. 2025 Jan;
30(2):104304.
PMID: 39884338
Decentralized clinical trial (DCT) approaches - in which trial activities are conducted at participants' homes - have the potential to improve representativeness. We present a study that compared the demographics...
2.
Kopanz J, Lagerwaard B, Beran M, Veldwijk J, Mader J, Pottler T, et al.
Clin Transl Sci
. 2024 Nov;
17(11):e70070.
PMID: 39575651
Decentralized clinical trials (DCTs), in which all or part of the trial activities are moved to the participants' immediate surroundings, promise to improve trial conduct. However, no evidence is available...
3.
de Jong A, Zuidgeest M, Santa-Ana-Tellez Y, de Boer A, Gardarsdottir H
Drug Discov Today
. 2024 Sep;
29(11):104180.
PMID: 39284522
Methodological and operational clinical trial innovation is needed to address key challenges associated with clinical trials, including limited generalizability and (s)low recruitment rates. In this article, we discuss how appropriate...
4.
de Jong A, Shahid N, Zuidgeest M, Santa-Ana-Tellez Y, Hogervorst M, Goettsch W, et al.
Value Health
. 2023 Dec;
27(3):294-300.
PMID: 38043711
Objectives: Decentralized clinical trial (DCT) approaches are clinical trials in which some or all trial activities take place closer to participants' proximities instead of a traditional investigative site. Data from...
5.
de Jong A, Santa-Ana-Tellez Y, Zuidgeest M, Grupstra R, Jami F, de Boer A, et al.
Br J Clin Pharmacol
. 2023 Jul;
89(12):3512-3522.
PMID: 37438875
Aims: Insights into the current practice of direct-to-participant (DtP) supply of investigational medicinal product (IMP) in the context of clinical trials conducted in Europe are needed, as regulations are unharmonized....
6.
Santa-Ana-Tellez Y, Lagerwaard B, de Jong A, Gardarsdottir H, Grobbee D, Hawkins K, et al.
Drug Discov Today
. 2023 Feb;
28(4):103520.
PMID: 36754144
There is increasing interest in clinical trials that use technologies and other innovative operational approaches to organise trial activities around trial participants instead of investigator sites. A range of terms...
7.
Boateng D, Kumke T, Vernooij R, Goetz I, Meinecke A, Steenhuis C, et al.
Contemp Clin Trials
. 2022 Dec;
125:107054.
PMID: 36529438
Background: The GetReal Trial Tool is a decision support tool to assess the impact of design choices on generalizability of clinical trials to routine clinical practice, while taking into account...
8.
Suman A, van Es J, Gardarsdottir H, Grobbee D, Hawkins K, Heath M, et al.
Trials
. 2022 Oct;
23(1):856.
PMID: 36203202
Background: The COVID-19 pandemic significantly impacted the conduct of clinical trials through delay, interruption or cancellation. Decentralised methods in clinical trials could help to continue trials during a pandemic. This...
9.
de Jong A, Grupstra R, Santa-Ana-Tellez Y, Zuidgeest M, de Boer A, Gardarsdottir H
BMJ Open
. 2022 Aug;
12(8):e063236.
PMID: 36038171
Objectives: Decentralised clinical trial activities-such as participant recruitment via social media, data collection through wearables and direct-to-participant investigational medicinal product (IMP) supply-have the potential to change the way clinical trials...
10.
van Rijssel T, de Jong A, Santa-Ana-Tellez Y, Boeckhout M, Zuidgeest M, van Thiel G
Drug Discov Today
. 2022 Jul;
27(10):103326.
PMID: 35870693
Decentralized clinical trials (DCTs) can be a valuable addition to the clinical trial landscape. However, the practice of DCTs is dependent on a regulatory system designed for conventional (site-based) trials....